The global platelet-rich plasma (PRP) market is poised for remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 12.1% from 2024 to 2034. According to recent market research, the PRP market, valued at USD 594 million in 2024, is expected to surge to USD 1.8 billion by 2034.
In 2023, the PRP market experienced a notable growth rate of 10.0%, fueled by several key factors driving its increasing adoption globally. PRP therapy has become a popular choice among both patients and healthcare professionals due to its non-invasive nature and minimal side effects. This therapeutic approach is increasingly utilized for treating sports injuries, orthopedic diseases, and a range of medical conditions, significantly contributing to its market growth.
Enhance Your Growth Tactics with Expert Insights: Download Checkout Full Reports Now
PRP therapy plays a pivotal role in regenerative medicine, aiding in the repair and regeneration of damaged tissues and cells. The expanding applications of PRP in treating conditions such as osteoarthritis, tendinitis, and chronic diseases among older adults are further propelling market demand.
Furthermore, the awareness of PRP therapy’s benefits in cosmetic procedures, such as reducing wrinkles and fine lines, is also driving market expansion. This awareness, coupled with advancements in technology and equipment for PRP treatments, is making PRP therapy more accessible and affordable for patients worldwide.
“The rising prevalence of chronic diseases, coupled with the effectiveness and growing acceptance of PRP therapy, is creating a robust market landscape,” noted FMI. “As the field of regenerative medicine continues to evolve, PRP is expected to play a crucial role in meeting the growing healthcare needs globally.”
The PRP market’s growth trajectory underscores its potential to revolutionize treatment paradigms across various medical disciplines. With advancements in technology and increasing patient awareness, the future of PRP therapy appears promising.
Key Takeaways from the Platelet-rich Plasma Market
- The platelet-rich plasma market is estimated to register a CAGR of 12.1% with a valuation of USD 1.8 billion by 2034.
- The pure platelet-rich fibrin (P-PRF) segment is anticipated to dominate the global market by registering a 42.1% share in 2024.
- With an 86.2% share, the autologous platelet-rich plasma is likely to drive the market by 2024.
- Japan is the leading country in the platelet-rich plasma market, with a CAGR of 13% from 2024 to 2034.
- The market of platelet-rich plasma in the United Kingdom is estimated to record a growth of 10.9% through 2034.
- The United Kingdom is the second-leading country in platelet-rich plasma, with an impressive growth of 12.4% through 2034.
Competitive Landscape:
Various established market participants and new startups attempting to build their presence have been in business for several years. These companies provide a wide range of platelet-rich plasma-related products and services, such as kits and devices, and focus on innovating products to meet the growing demand. Some prominent companies in the market include Harvest Technologies Corp., Zimmer Biomet Holdings Inc., Arthrex, Inc., and Arteriocyte Medical Systems, Inc.
Elevate Your Strategy with Full Report Access – Get It Now
Recent Development:
Zimmer Biomet Holdings Inc., a medical technology company, signed a strategic collaboration with OSSIS, a hip replacement treatment company based in New Zealand, in 2021. The partnership aimed to promote Zimmer Biomet’s patient-specific 3D-printed titanium hip replacement joints throughout Asia.
Key Market Segments:
By Product Type:
- Pure-Platelet-rich Plasma (P-PRP)
- Leukocyte-Platelet-rich Plasma (L-PRP)
- Leukocyte-Platelet-rich Fibrin (L-PRF)
By Origin Type:
- Autologous
- Homologous
- Allogenic
By Application Type:
- Orthopedic Surgery
- Cosmetic Surgery
- General Surgery
- Neurosurgery
- Other Surgeries (Urological, Cardiothoracic, Periodontal, and Oral and Maxillofacial)
By Region:
- North America
- Latin America
- East Asia
- South Asia
- Europe
- Oceania
- The Middle East and Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
